Volunteers gathered at the Medical Military Academy from 7:15 this morning for the testing of the Nanogen Pharmaceutical Biotechnology JSC’s Nanocovax vaccine. They were also provided with another health screening check before the tests.
Around 560 volunteers have been selected for the second testing, divided into groups to be injected with doses of 25mcg, 50mcg, and 75mcg. One group received a placebo to help compare with those who are provided with the vaccine. This is intended to assess the efficiency of the vaccine, said Chu Van Men, Director of the Military Medical University's Centre for Clinical Trials and Bioequivalence.
A volunteer of the second testing of the vaccine
"However, all volunteers won’t know whether they’re provided with the vaccine or the placebo, which is aimed to ensure the scientific research,” Men added.
This morning, the same testing was carried out in parallel at both the Medical Military Academy in Hanoi and at a medical centre in Ben Luc District, the southern province of Long An.
Unlike the first trial of the vaccine, this time, after the injection, volunteers only stayed at the institute or the medical centre in Long An for 60 minutes. They could then return home and were medically monitored by local health authorities.
Nguyen Ngo Quang, deputy director of the Health Ministry's Department of Science, Technology and Training, the result of the second testing is expected to be announced in 2-2.5 months to come.
